After confirming by in silico analyses that low RAP2A expression levels in GBM patients were associated with a poor prognosis, we decided to use established GBM cell lines to investigate in neurosphere cell cultures whether the downregulation of RAP2A was affecting the properties of GSCs. Here, RAP2A is linked to glioblastoma.